Saba Capital Management, L.P. 13D and 13G filings for Tekla Life Sciences Investors:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-01 9:49 pm Purchase |
2025-03-31 | 13D | Tekla Life Sciences Investors HQL |
Saba Capital Management, L.P. | 3,188,405 11.360% |
3,188,405 (New Position) |
Filing |